Total Hip Replacement Revision Rates Vary With Type of Material Used
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 12, 2024 -- For patients undergoing primary total hip replacement (THR), the rate of revision varies by type of material used in the bearing surface, according to a study published online Nov. 7 in PLOS Medicine.
Michael R. Whitehouse, M.B., Ch.B., from the University of Bristol Medical School in the United Kingdom, and colleagues examined the revision rate of primary THR reported in the National Joint Registry. Data were analyzed for 1,026,481 primary THRs (monobloc: 378,979; modular: 647,502), of which 2 percent subsequently underwent a revision episode (monobloc: 7,381; modular: 13,488).
The researchers found that for monobloc implants, the all-cause risk for revision for monobloc acetabular implants was higher for patients with a cobalt chrome or stainless steel head and non-highly crosslinked polyethylene (HCLPE) cup versus those with a cobalt chrome head and HCLPE cup (hazard ratio at 10 years after surgery, 1.28 and 1.18, respectively). Patients with a delta ceramic head and HCLPE cup implant had a lower risk for revision at any postoperative period (hazard ratio at 10 years, 0.61). For modular implants, the all-cause risk for revision varied inconsistently for patients with modular acetabular implants compared with patients with a cobalt chrome head and HCLPE liner primary THR. The risk for revision was lower throughout the postoperative period for THRs with a delta ceramic or oxidized zirconium head and HCLPE liner (hazard ratios, 0.79 and 0.65, respectively).
"Further work is required to determine the association of implant bearing materials with the risk of rehospitalization, reoperation other than revision, mortality, and the cost-effectiveness of these materials," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-13 06:00
Read more
- FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet Recovered
- Genetic Testing Rate Lower for Blacks With Inherited Retinal Diseases
- Knowledge of Abdominal Aortic Calcification Results Improves Some CVD Risk Factors
- FDA Approves Emrosi for Rosacea in Adults
- Science Reveals Why Cancer Immunotherapies Can Sometimes Harm the Heart
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions